{"version":"1.0","type":"link","title":"Twelve mutations, three trials, and five different labels: PARP inhibitors regulatory inconsistencies in prostate cancers.","author_name":"Barjesteh van Waalwijk van Doorn-Khosrovani S 외","author_url":"https://prs-insight.online/author/Barjesteh%20van%20Waalwijk%20van%20Doorn-Khosrovani%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/133154","thumbnail_width":1200,"thumbnail_height":630}